Position in JNJ
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$82,794
+$3,596 QoQ
Shares Held
326
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#4,575
of 4,664 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LGT Financial Advisors LLC holds $591,610 across 2 Drug Manufacturers - General names. JNJ ranks #2 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,022 | $508,816 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
326 | $82,794 |
All Filings in JNJ
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,794 | 326 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $79,198 | 324 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $66,844 | 323 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $59,519 | 321 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $48,574 | 318 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $52,405 | 316 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $72,743 | 503 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $81,191 | 501 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $72,787 | 498 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $78,462 | 496 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $87,774 | 560 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $87,843 | 564 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $391,785 | 2,367 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $366,575 | 2,365 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||